3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
29
Pain, Postoperative
10
Colorectal Neoplasms
10
Neoplasms
8
Brain Neoplasms
8
Stomach Neoplasms
7
Prostatic Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Melanoma
5
Ovarian Neoplasms
4
Hemorrhage
4
Head and Neck Neoplasms
4
Agnosia
4
Rectal Neoplasms
3
Neurotoxicity Syndromes
3
Nasopharyngeal Carcinoma
3
Myoma
3
Multiple Endocrine Neoplasia Type 1
3
Meningioma
3
Lymphoma, Non-Hodgkin
3
Leiomyoma
3
Glioblastoma
3
Delirium
3
Colonic Neoplasms
3
Chronic Pain
3
Warts
2
Uterine Cervical Neoplasms
2
Stomatitis
2
Skin Neoplasms
2
Interventions
Tomography, X-Ray Computed
2
Serum Albumin, Human
2
Proctectomy
2
Indocyanine Green
2
Ileostomy
2
Esophagectomy
2
Colectomy
2
Bioseal
2
obsidian
1
Water
1
Tobramycin
1
Tissue Adhesives
1
Surgical Procedures, Operative
1
Surgical Fixation Devices
1
Stents
1
Somatostatin
1
Sodium Chloride
1
Saline Solution
1
Robotic Surgical Procedures
1
Proctoscopy
1
Neomycin
1
Neoadjuvant Therapy
1
Negative-Pressure Wound Therapy
1
Mortality
1
Metronidazole
1
Marital Status
1
Laparotomy
1
Inulin
1
Hematologic Tests
1
Fibrin Tissue Adhesive
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anastomotic Leak
×
Sodium Chloride
×
Clear all
NCT02682485
2023-04-26
SES-DTA
University of Chicago
Phase 2
Withdrawn